MedPath

University of Oxford

University of Oxford logo
🇬🇧United Kingdom
Ownership
Private
Established
1096-01-01
Employees
10K
Market Cap
-
Website
http://www.ox.ac.uk

Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant

Phase 1
Not yet recruiting
Conditions
Plasmodium Falciparum Malaria
Interventions
Biological: Pfs25-IMX313, Pfs48/45
First Posted Date
2024-08-12
Last Posted Date
2025-05-21
Lead Sponsor
University of Oxford
Target Recruit Count
56
Registration Number
NCT06549257

Lung Innate Immunity and Microbiome After Tuberculosis Exposure

Recruiting
Conditions
Tuberculosis
Latent Tuberculosis
First Posted Date
2024-07-30
Last Posted Date
2025-01-22
Lead Sponsor
University of Oxford
Target Recruit Count
50
Registration Number
NCT06526689
Locations
🇬🇧

Churchill Hospital, Oxford, Oxfordshire, United Kingdom

🇬🇧

Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxon, United Kingdom

🇬🇧

Grove Building, Royal Free NHS Foundation Trust, London, United Kingdom

The Oxford Pleural Infection Endotyping Study

Completed
Conditions
Pleural Infection
Pleural Diseases
Pleural Infections and Inflammations
Pleural Empyema
Pleural Infection Bacterial
Pleural Effusion
First Posted Date
2024-07-22
Last Posted Date
2024-07-22
Lead Sponsor
University of Oxford
Target Recruit Count
80
Registration Number
NCT06513689
Locations
🇬🇧

Laboratory of Pleural Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom

Assessing Antiviral Treatments in Early Symptomatic RSV

Phase 2
Not yet recruiting
Conditions
Respiratory Syncytial Virus, Human
Respiratory Syncytial Virus
Interventions
First Posted Date
2024-07-05
Last Posted Date
2024-07-11
Lead Sponsor
University of Oxford
Target Recruit Count
1000
Registration Number
NCT06488300
Locations
🇹🇭

Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

Frontosubthalamic Networks in Parkinson's Disease.

Not Applicable
Recruiting
Conditions
Parkinson Disease
Impulse Control Disorder
Interventions
Other: DBS on/off
First Posted Date
2024-07-03
Last Posted Date
2025-04-02
Lead Sponsor
University of Oxford
Target Recruit Count
20
Registration Number
NCT06485986
Locations
🇬🇧

John Radcliffe Hospital, Oxford, United Kingdom

Glutamate Activity in Depression (GLADE)

Not Applicable
Not yet recruiting
Conditions
Depression
Interventions
Other: Flickering Checkerboard Stimulation
First Posted Date
2024-07-01
Last Posted Date
2024-07-01
Lead Sponsor
University of Oxford
Target Recruit Count
40
Registration Number
NCT06482606
Locations
🇬🇧

University of Oxford, Oxford, Oxfordshire, United Kingdom

COV-CHIM02: SARS-CoV-2 Omicron BA.5 Subvariant Dose Finding Infection Study

Phase 1
Recruiting
Conditions
SARS-CoV-2 Infection
Interventions
Biological: Omicron BA.5 SARS-CoV-2 challenge virus
First Posted Date
2024-06-27
Last Posted Date
2024-06-27
Lead Sponsor
University of Oxford
Target Recruit Count
45
Registration Number
NCT06478420
Locations
🇬🇧

Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

(GluEsk) Glutamate and Esketamine

Not Applicable
Not yet recruiting
Conditions
Depression
Interventions
First Posted Date
2024-05-29
Last Posted Date
2024-06-27
Lead Sponsor
University of Oxford
Target Recruit Count
12
Registration Number
NCT06432322
Locations
🇬🇧

Department of Psychiatry, University of Oxford, Oxford, Oxfordshire, United Kingdom

Acceptability, Feasibility, Safety and Efficacy of a Optimized Rehabilitation Program for Treated Patients With Spinal Muscular Atrophy (SMA).

Not Applicable
Active, not recruiting
Conditions
Spinal Muscular Atrophy
Interventions
Other: Optimized rehabilitation program
First Posted Date
2024-05-17
Last Posted Date
2025-02-03
Lead Sponsor
University of Oxford
Target Recruit Count
14
Registration Number
NCT06419322
Locations
🇬🇧

Oxford Brookes University, Oxford, Oxfordshire, United Kingdom

Baby-CINO: CaffeINe Treatment Optimisation in Premature Infants

Recruiting
Conditions
Infant,Premature
Caffeine
Interventions
First Posted Date
2024-05-16
Last Posted Date
2024-05-16
Lead Sponsor
University of Oxford
Target Recruit Count
30
Registration Number
NCT06416956
Locations
🇬🇧

Newborn Care Unit, John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath